134 related articles for article (PubMed ID: 4687749)
1. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
Dencker SJ; Lindberg D; Malm U
Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
[No Abstract] [Full Text] [Related]
2. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
Ferrari P; Robotti E; Nardini M
Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
[No Abstract] [Full Text] [Related]
3. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
Wasik A
Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
Bukowczyk A; Wasik A; Horodnicki J
Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
[No Abstract] [Full Text] [Related]
5. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
Stenson RL; Donion PT; Meyer JE
Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
[No Abstract] [Full Text] [Related]
6. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G
Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070
[No Abstract] [Full Text] [Related]
7. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
Huygens H; Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
[No Abstract] [Full Text] [Related]
8. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
Fanali A; Nardini M; Sorgona F
Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
[No Abstract] [Full Text] [Related]
9. Amantadine in drug-induced extrapyramidal signs: a comparative study.
Ananth J; Sangani H; Noonan JP
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908
[TBL] [Abstract][Full Text] [Related]
10. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
Deniker P; Ginestet D
Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
[No Abstract] [Full Text] [Related]
11. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
Delaunay J; Guibert S
Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
[No Abstract] [Full Text] [Related]
12. The extrapyramidal neuroleptic syndrome: description and measurement.
Elie R; Gagnon MA; Lamontagne Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
[No Abstract] [Full Text] [Related]
13. [Late irreversible extrapyramidal syndrome following neuroleptic use].
Boucebci M
Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
[No Abstract] [Full Text] [Related]
14. [Treatment of extrapyramidal adverse effects in neuroleptic therapy].
Malm U
Nord Psykiatr Tidsskr; 1972; 26(6):348-50. PubMed ID: 4634569
[No Abstract] [Full Text] [Related]
15. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
Neu C; Dimascio A; Demirgian E
Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
[No Abstract] [Full Text] [Related]
16. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
Simpson GM; Beckles D; Isalski Z; Lee JH
J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
[No Abstract] [Full Text] [Related]
17. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Kamianov IM; Kupisk AG; Katsen IZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
[No Abstract] [Full Text] [Related]
18. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Merrick EM; Schmitt PP
Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
[No Abstract] [Full Text] [Related]
19. The rabbit syndrome. A peculiar extrapyramidal reaction.
Villeneuve A
Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
[No Abstract] [Full Text] [Related]
20. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
Encephale; 1976; 2(2):115-21. PubMed ID: 776591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
